Taking stock of the drug industry, from the lab to the medicine chestJune 26, 2025Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Barbara Johnston/University of Notre Dame Generic cancer drugs used around the world fail quality tests, investigation shows Investigation finds too little or too much active ingredient in about a fifth of all chemotherapy samples; patients in 100 countries at risk By Paul Eccles, Andjela Milivojevic, and and Ramu Sapkota — TBIJ CDC vaccine advisers recommend Merck's RSV therapy for babies It was the first vote taken by the newly constituted panel, made up of members selected by health secretary Robert F. Kennedy Jr. By Helen Branswell STAT+ | Here's how Insmed grows to be the next $100 billion biotech In this edition of "Adam's Biotech Scorecard," Adam also relays a feel-good investor story made possible by Nektar Therapeutics. By Adam Feuerstein David Goldman/AP CDC advisory panel, selected by RFK Jr., recommends thimerosal be dropped from flu vaccines The preservative, largely considered safe and rarely used anymore, has long been a target of antivax activists. ACIP panel vote seen as a win for Kennedy. By Helen Branswell Vaccine policy frays, CDC nominee in the hot seat, & obesity drug side effects This week on the podcast: What does the fracturing of vaccine policy mean for U.S. health care? And will the potential CDC head stand up to RFK Jr.? By Allison DeAngelis and Adam Feuerstein More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments